REQUEST A DEMO
Total
USD $0.00
Search more companies

Mupv Apteka N 219 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Mupv Apteka N 219 Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Mupv Apteka N 219 is an enterprise in Russia, with the main office in Vladivostok. It operates in the Pharmacies and Drug Stores industry. The company was established on May 30, 1994. In 2023, the company reported a net sales revenue drop of 3.61%. There was a total growth of 1.76% in Mupv Apteka N 219’s total assets over the same period. The net profit margin of Mupv Apteka N 219 increased by 0.15% in 2023.

Headquarters
Neibuta, 65A
Vladivostok; Primorsky Krai; Postal Code: 690109

Contact Details: Purchase the Mupv Apteka N 219 report to view the information.

Basic Information
Outstanding Shares:
Purchase the Mupv Apteka N 219 report to view the information.
Registered Capital:
Purchase the Mupv Apteka N 219 report to view the information.
Incorporation Date:
May 30, 1994
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Vladfarm AO
12.7625%
Company Performance
Financial values in the chart are available after Mupv Apteka N 219 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-3.61%
Total operating revenue
-3.61%
Operating profit (EBIT)
11.24%
Net Profit (Loss) for the Period
7.05%
Total assets
1.76%
Total equity
0.85%
Operating Profit Margin (ROS)
0.58%
Net Profit Margin
0.15%
Return on Equity (ROE)
0.07%
Quick Ratio
-0.44%
Cash Ratio
-0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?